SANA (STOCKS)
Sana Biotechnology, Inc. Common Stock
$3.750000
-0.020000 (-0.53%)
Prev close: $3.770000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Steven D. Harr
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,302.49M
- Employees
- 194
- P/E (TTM)
- -4.82
- P/B (TTM)
- 7.30
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $218.75M |
| Research and Development | $124.48M |
| Other Operating Expenses | $94.27M |
| Operating Income/Loss | -$218.75M |
| Income/Loss From Continuing Operations After Tax | -$211.82M |
| Income/Loss From Continuing Operations Before Tax | -$211.82M |
| Net Income/Loss | -$211.82M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$211.82M |
| Net Income/Loss Available To Common Stockholders, Basic | -$211.82M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.76 |
| Diluted Earnings Per Share | -$0.76 |
| Basic Average Shares | 554,462,000 |
| Diluted Average Shares | 554,462,000 |
| Assets | $431.52M |
| Current Assets | $170.63M |
| Noncurrent Assets | $260.89M |
| Fixed Assets | $25.16M |
| Intangible Assets | $59.20M |
| Other Non-current Assets | $176.53M |
| Liabilities | $276.95M |
| Current Liabilities | $123.75M |
| Accounts Payable | $1.36M |
| Wages | $8.84M |
| Other Current Liabilities | $113.55M |
| Noncurrent Liabilities | $153.20M |
| Equity | $154.57M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $154.57M |
| Liabilities And Equity | $431.52M |
| Net Cash Flow From Operating Activities | -$132.24M |
| Net Cash Flow From Operating Activities, Continuing | -$132.24M |
| Net Cash Flow From Investing Activities | -$102.60M |
| Net Cash Flow From Investing Activities, Continuing | -$102.60M |
| Net Cash Flow From Financing Activities | $220.64M |
| Net Cash Flow From Financing Activities, Continuing | $220.64M |
| Net Cash Flow | -$14.20M |
| Net Cash Flow, Continuing | -$14.20M |
| Comprehensive Income/Loss | -$211.86M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$211.89M |
| Other Comprehensive Income/Loss | -$105.82M |